CHEMGENEX PHARMACEUTICALS
ChemGenex Pharmaceuticals Ltd, an integrated biopharmaceutical development company, engages in the discovery and the development of oncology drugs. The company's product candidates include omacetaxine mepesuccinate, an investigational small molecule agent that is in Phase 2/3 clinical trial for the treatment of chronic myelogenous leukemia, and is also in Phase 2 clinical trials for the treatment of acute myelogenous leukemia and myelodysplastic syndrome; and Quinamed, which is in Phase 2 clinical trial for the treatment of hormone refractory prostate cancer. It was formerly known as AGT Biosciences Limited and changed its name to ChemGenex Pharmaceuticals Ltd in June 2004. The company was founded in 1958 and is headquartered in Geelong, Australia.
CHEMGENEX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care
Founded:
1958-01-01
Address:
Geelong, Victoria, Australia
Country:
Australia
Website Url:
http://www.chemgenex.com
Total Employee:
11+
Status:
Active
Contact:
61 3 5223 9900
Email Addresses:
[email protected]
Total Funding:
21 M AUD
Technology used in webpage:
SPF
Similar Organizations
Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Current Advisors List
Current Employees Featured
Investors List
Alta Partners
Alta Partners investment in Series A - ChemGenex Pharmaceuticals
GBS Ventures
GBS Ventures investment in Series A - ChemGenex Pharmaceuticals
Official Site Inspections
http://www.chemgenex.com
- Host name: 204.12.13.107
- IP address: 204.12.13.107
- Location: Denver United States
- Latitude: 39.7501
- Longitude: -104.9957
- Metro Code: 751
- Timezone: America/Denver
- Postal: 80202
